# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-005782
Filing Date
2024-04-25
Accepted
2024-04-25 16:36:11
Documents
96
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tmb-20240331x10q.htm iXBRL | 10-Q | 2307612
2 | EX-10.1 | tmb-20240331xex10d1.htm | EX-10.1 | 232715
3 | EX-31.1 | tmb-20240331xex31d1.htm | EX-31.1 | 10921
4 | EX-31.2 | tmb-20240331xex31d2.htm | EX-31.2 | 10732
5 | EX-32.1 | tmb-20240331xex32d1.htm | EX-32.1 | 5933
6 | EX-32.2 | tmb-20240331xex32d2.htm | EX-32.2 | 6128
7 | GRAPHIC | tmb-20240331xex10d1001.jpg | GRAPHIC | 5885
8 | GRAPHIC | tmb-20240331xex10d1002.jpg | GRAPHIC | 19533
| Complete submission text file | 0001558370-24-005782.txt |  | 12916096

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | tmb-20240331.xsd | EX-101.SCH | 83119
10 | EX-101.CAL | tmb-20240331_cal.xml | EX-101.CAL | 74972
11 | EX-101.DEF | tmb-20240331_def.xml | EX-101.DEF | 410501
12 | EX-101.LAB | tmb-20240331_lab.xml | EX-101.LAB | 787446
13 | EX-101.PRE | tmb-20240331_pre.xml | EX-101.PRE | 624026
100 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20240331x10q_htm.xml | XML | 2619197

Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 24876991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)